Mechanistic and pharmacological assessment of murine IL-23 mediated psoriasiform dermatitis; implications for drug discovery
Authors:
- Stephen B. GauldSGStephen B. Gauld
- Donna GauvinDGDonna Gauvin
- Lauren OlsonLOLauren Olson
- Stephanie PaulsboeSPStephanie Paulsboe
- Rebecca M. EdelmayerRERebecca M. Edelmayer
- Joseph WetterJWJoseph Wetter
- Katherine SalteKSKatherine Salte
- Yibing WangYWYibing Wang
- Susan HuangSHSusan Huang
- Prisca HonorePHPrisca Honore
Open Access
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Journal of Dermatological Science
- Vol. 92 (1) , 45-53
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cross-Study Homogeneity of Psoriasis Gene Expression in Skin across a Large Expression RangePLOS ONE, 2013
- Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patientsBMC Genomics, 2013
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin InflammationImmunity, 2011
- Resolved Psoriasis Lesions Retain Expression of a Subset of Disease-Related GenesJournal of Investigative Dermatology, 2011
- A Subpopulation of CD163-Positive Macrophages Is Classically Activated in PsoriasisJournal of Investigative Dermatology, 2010
- Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathwaysNature Genetics, 2009
- Type I Interferon: Potential Therapeutic Target for Psoriasis?PLOS ONE, 2008
- Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responsesJournal of Experimental Medicine, 2007
- Targeting TNFα rapidly reduces density of dendritic cells and macrophages in psoriatic plaques with restoration of epidermal keratinocyte differentiationJournal of Dermatological Science, 2007
- IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesisJournal of Experimental Medicine, 2006